Psychophysiological aspects of amphetamine-methamphetamine abuse

Journal of Psychology: Interdisciplinary and Applied

Volumn 132, Issue 2, 1998, Pages 227-237

  Murray, John B ^a  

^a ST JOHN'S UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; METHAMPHETAMINE;

ADDICTION; DRUG ABUSE; HUMAN; PATHOPHYSIOLOGY; PSYCHOSIS; REVIEW; WITHDRAWAL SYNDROME;

AMPHETAMINE-RELATED DISORDERS; AMPHETAMINES; BEHAVIOR, ADDICTIVE; HUMANS; METHAMPHETAMINE; PSYCHOSES, SUBSTANCE-INDUCED; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0032014629     PISSN: 00223980     EISSN: 19401019     Source Type: Journal    
DOI: 10.1080/00223989809599162     Document Type: Article

References (42)

1. Alldredge, B. K., Lowenstein, D. H., & Simon, R. P. (1989). Seizures associated with recreational drug abuse. Neurology, 39, 1037-1039.
2. Alvarez, F. J., Queipo, D., Del Rio, C., & Garcia, M. C. (1992). Pattern of drug use in Castille and Leon (Spain). British Journal of Addiction, 87, 1153-1160.
3. Asnis, S. F., & Smith, R. C. (1978). Amphetamine abuse and violence. Journal of Psychedelic Drugs, 10, 371-377.
4. Baberg, H. T., Nelesen, R. A., & Dimsdale, J. E. (1996). Amphetamine use: Return of an old scourge in a consultation psychiatry setting. American Journal of Psychiatry, J53, 789-793.
5. Bailey, D. N. (1987). Amphetamine detection during toxicology screening of a university medical center patient population. Journal of Toxicology-Clinical Toxicology, 25, 399-409.
6. Bell, D. S. (1965). Comparison of amphetamine psychosis and schizophrenia. British Journal of Psychiatry, 3, 701-707.
7. Bell, D. S. (1973). The experimental reproduction of amphetamine psychosis. Archives of General Psychiatry, 29, 35-40.
8. Connell, P. H. (1968). The use and abuse of amphetamines. Practitioner, 200, 234-243.
9. Conrad, S., Hughes, P., Baldwin, D. C., Jr., Achenbach, K. E., & Sheehan, D. V. (1988). Substance use by fourth-year students at 13 U.S. medical schools. Journal of Medical Education, 63, 747-758.
10. Cook, C. E. (1991). Pyrolytic characteristics, pharmacokinetics, and bioavailability of smoked heroin, cocaine, phencyclidine, and methamphetamine. In M. A. Miller & N. J. Kozel (Eds.), Methamphetamine abuse: Epidemiologic issues and implications (Research Monograph 115, pp. 6-23). Rockville, MD: National Institute on Drug Abuse.
11. Espelin, D., & Done, A. K. (1968). Amphetamine poisoning: Effectiveness of chlorpro-mazine. New England Journal of Medicine, 278, 1361-1365.
12. Flaum, M., & Schultz, S. K. (1996). When does amphetamine-induced psychosis become schizophrenia? American Journal of Psychiatry, 153, 812-815.
13. Griffith, J. D., Cavanaugh, J., & Oates, J. (1969). Schizophreniform psychosis induced by large-dose administration of D-amphetamine. Journal of Psychedelic Drugs, 2, 42-48.
14. Hall, J. N., Uchman, R. S., & Dominquez, R. (1989). Methamphetamine abuse in the United States. Rockville, MD: National Institute on Drug Abuse.
15. Hart, J. B., McChesney, J. D., Greif, F. M., & Schulz, G. (1972). Composition of illicit drugs and the use of drug analysis in abuse abatement. Journal of Psychedelic Drugs, 5, 83-88.
16. Hoffman, B. B., & Lefkowitz, R. J. (1996). Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In J. G. Hardman, P. B. Molinoff, R. W. Ruddon, L. E. Limbird, & A. G. Gillman (Eds.), The pharmacological basis of therapeutics (9th ed., pp. 199-248). New York: McGraw-Hill.
17. Hyman, S. E. (1996). Shaking out the cause of addiction. Science, 273, 611-612.
18. Irvine, G. D., & Chin, L. (1991). The environmental impact and adverse health effects of the clandestine manufacture of methamphetamine. In M. A. Miller & N. J. Kozel (Eds.), Methamphetamine abuse: Epidemiologic issues and implications (Research Monograph 115, pp. 33-46). Rockville, MD: National Institute on Drug Abuse.
19. Johnston, L. D., O’Malley, P. M., & Bachman, J. G. (1993). National survey results on drug use from Monitoring the Future Study, 1975-1992. Rockville, MD: National Institute on Drug Abuse.
20. Kane, F. J., Keeler, M. H., & Reifler, C. B. (1969). Neurological crises following methamphetamine (letter). Journal of the American Medical Association, 210, 556-557.
21. King, G. R., & Ellinwood, E. H., Jr. (1992). Amphetamines and other stimulants. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance abuse: A comprehensive textbook (pp. 247-270). Baltimore, MD: Williams & Wilkins.
22. Klee, H. (1992). A new target for behavioural research Amphetamine abuse. British Journal of Addiction, 87, 439-446.
23. Kramer, J. C., Fischman, V. S., & Littlefield, D. C. (1967). Amphetamine abuse: Pattern and effects of high doses taken intravenously. Journal of the American Medical Association, 201, 305-309.
24. Low, D. B., Jones, M., Carter, B., & Cadoret, R. J. (1984). The effect of d-amphetamine and ephedrine on smoking attitude and behavior. Addictive Behaviors, 9, 335-345.
25. Lowinson, J. H., Ruiz, P., Millman, R. B., & Langrod, J. G. (Eds.). (1992). Substance abuse: A comprehensive textbook. Baltimore, MD: Williams & Wilkins.
26. Machiyama, Y. (1992). Chronic methamphetamine intoxication model of schizophrenia in animals. Schizophrenia Bulletin, 18, 107-113.
27. Miller, M. A., & Kozel, N. J. (Eds.). (1991). Methamphetamine abuse: Epidemiologic issues and implications (Monograph 115). Rockville, MD: National Institute on Drug Abuse.
28. Morgan, J. B., & Kagan, D. (1978). Street amphetamine quality and the Controlled Substances Act of 1970. Journal of Psychedelic Drugs, 10, 303-317.
29. Newmeyer, J. A. (1978). The epidemiology of the use of amphetamine and related substances. Journal of Psychedelic Drugs, 10, 293-302.
30. Puder, K. S., Kagan, D. V., & Morgan, J. P. (1988). Illicit methamphetamine: Analysis, synthesis, and availability. American Journal of Drug and Alcohol Abuse, 14, 464-473.
31. Sato, M., Numachi, Y., & Hamamura, T. (1992). Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophrenia Bulletin, 18, 115-122.
32. Selden, L. S. (1991). Neurotoxicity of methamphetamine: Mechanisms of action and issues related to aging. In M. A. Miller & N. J. Kozel (Eds.), Methamphetamine abuse: Epidemiologic issues and implications (Research Monograph 115, pp. 24-32). Rockville, MD: National Institute on Drug Abuse.
33. Selden, L. S., Woolverton, W. L., Lorens, S. A., Williams, J. E. G., Corwin, R. L., Hata, N., & Olimski, M. (1993). Behavior consequences of partial monamine depletion in the CNS after methamphetic-like drugs: The conflict between pharmacology and toxicology. In L. Erinoff (Ed.), Assessing neurotoxicity of drugs of abuse (Research Monograph 136, pp. 34-52). Rockville, MD: National Institute on Drug Abuse.
34. Smith, D. E. (1969). Analysis of variables in high dose methamphetamine dependence. Journal of Psychedelic Drugs, 2, 132-137.
35. Smith, R. (1969). Traffic in speed: Illegal manufacture and distribution. Journal of Psychedelic Drugs, 2, 30-41.
36. Smith, R. C. (1969). The world of the Haight-Ashbury speed freak. Journal of Psychedelic Drugs, 2, 172-188.
37. Smith, D. E., & Fischer, C. M. (1969). Acute amphetamine toxicity. Journal of Psychedelic Drugs, 2, 49-54.
38. Snyder, S. H. (1973). Amphetamine psychosis: A “model” schizophrenia mediated by catecholamines. American Journal of Psychiatry, 130, 61-67.
39. Spotts, J. V., & Spotts, C. A. (Eds.). (1980). Use and abuse of amphetamine and its substitutes (Research Issues 25, pp. 7-14). Rockville, MD: National Institute on Drug Abuse.
40. Ungerleider, J. T. (1978). Less common uses of amphetamine. Journal of Psychedelic Drugs, 10, 327-329.
41. Watson, R., Hartmann, E., & Schildkraut, J. J. (1972). Amphetamine withdrawal: Affective state, sleep patterns, and MHPG excretion. American Journal of Psychiatry, 129, 263-269.
42. Wesson, D. R., & Smith, D. E. (1978). A clinical approach to diagnosis and treatment of amphetamine abuse. Journal of Psychedelic Drugs, 10, 343-350.